Antifungal Drug Market Research Report by Infection Type (Superficial Fungal Infection and Systemic Fungal infection), by Type (Allylamines, Azoles, Echinocandins, and Polyenes), by Form, by Therapeutic Indications - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Antifungal Drug Market is expected to grow from USD 12,553.68 Million in 2020 to USD 16,149.28 Million by the end of 2025.
2. The Global Antifungal Drug Market is expected to grow from EUR 11,007.30 Million in 2020 to EUR 14,159.99 Million by the end of 2025.
3. The Global Antifungal Drug Market is expected to grow from GBP 9,785.51 Million in 2020 to GBP 12,588.26 Million by the end of 2025.
4. The Global Antifungal Drug Market is expected to grow from JPY 1,339,795.76 Million in 2020 to JPY 1,723,537.39 Million by the end of 2025.
5. The Global Antifungal Drug Market is expected to grow from AUD 18,229.61 Million in 2020 to AUD 23,450.90 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Antifungal Drug to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Infection Type, the Antifungal Drug Market studied across Superficial Fungal Infection and Systemic Fungal infection.
Based on Type, the Antifungal Drug Market studied across Allylamines, Azoles, Echinocandins, and Polyenes. The Allylamines further studied across Butenafine, Naftifine, and Terbinafine. The Azoles further studied across Imidazoles, Thiazoles, and Voricanazole. The Echinocandins further studied across Anidulafungin, Caspofungin, and Micafungin. The Polyenes further studied across Amphotericin B, Candicidin, Hamycin, and Natamycin.
Based on Form, the Antifungal Drug Market studied across Ointments, Powder, and Tablets.
Based on Therapeutic Indications, the Antifungal Drug Market studied across Aspergillosis, Candidiasis, and Dermatophytosis.
Based on Geography, the Antifungal Drug Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Antifungal Drug Market including Abbott Laboratories, Astellas Pharma Inc., Bayer HealthCare Pharmaceuticals LLC, Cadila Pharmaceuticals Limited, Cipla, Inc., Eli Lilly and Company, Enzon Pharmaceuticals, Inc., G&W Laboratories LLC, Gilead Sciences, Inc., Johnson & Johnson, Kramer Laboratories, Inc., Lakewood-Amedex, Inc., Merck KGaA, Novartis AG, Pfizer, Inc., Ranbaxy Laboratories Limited, Sanofi S.A., SCYNEXIS, Inc., Sigma-Aldrich, Inc., and Wockhardt Limited.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Antifungal Drug Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Antifungal Drug Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antifungal Drug Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antifungal Drug Market?
4. What is the competitive strategic window for opportunities in the Global Antifungal Drug Market?
5. What are the technology trends and regulatory frameworks in the Global Antifungal Drug Market?
6. What are the modes and strategic moves considered suitable for entering the Global Antifungal Drug Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Antifungal Drug Market is expected to grow from USD 12,553.68 Million in 2020 to USD 16,149.28 Million by the end of 2025.
2. The Global Antifungal Drug Market is expected to grow from EUR 11,007.30 Million in 2020 to EUR 14,159.99 Million by the end of 2025.
3. The Global Antifungal Drug Market is expected to grow from GBP 9,785.51 Million in 2020 to GBP 12,588.26 Million by the end of 2025.
4. The Global Antifungal Drug Market is expected to grow from JPY 1,339,795.76 Million in 2020 to JPY 1,723,537.39 Million by the end of 2025.
5. The Global Antifungal Drug Market is expected to grow from AUD 18,229.61 Million in 2020 to AUD 23,450.90 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Antifungal Drug to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Infection Type, the Antifungal Drug Market studied across Superficial Fungal Infection and Systemic Fungal infection.
Based on Type, the Antifungal Drug Market studied across Allylamines, Azoles, Echinocandins, and Polyenes. The Allylamines further studied across Butenafine, Naftifine, and Terbinafine. The Azoles further studied across Imidazoles, Thiazoles, and Voricanazole. The Echinocandins further studied across Anidulafungin, Caspofungin, and Micafungin. The Polyenes further studied across Amphotericin B, Candicidin, Hamycin, and Natamycin.
Based on Form, the Antifungal Drug Market studied across Ointments, Powder, and Tablets.
Based on Therapeutic Indications, the Antifungal Drug Market studied across Aspergillosis, Candidiasis, and Dermatophytosis.
Based on Geography, the Antifungal Drug Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Antifungal Drug Market including Abbott Laboratories, Astellas Pharma Inc., Bayer HealthCare Pharmaceuticals LLC, Cadila Pharmaceuticals Limited, Cipla, Inc., Eli Lilly and Company, Enzon Pharmaceuticals, Inc., G&W Laboratories LLC, Gilead Sciences, Inc., Johnson & Johnson, Kramer Laboratories, Inc., Lakewood-Amedex, Inc., Merck KGaA, Novartis AG, Pfizer, Inc., Ranbaxy Laboratories Limited, Sanofi S.A., SCYNEXIS, Inc., Sigma-Aldrich, Inc., and Wockhardt Limited.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Antifungal Drug Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Antifungal Drug Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antifungal Drug Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antifungal Drug Market?
4. What is the competitive strategic window for opportunities in the Global Antifungal Drug Market?
5. What are the technology trends and regulatory frameworks in the Global Antifungal Drug Market?
6. What are the modes and strategic moves considered suitable for entering the Global Antifungal Drug Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Infection Type Outlook
3.4. Type Outlook
3.5. Form Outlook
3.6. Therapeutic Indications Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of fungal infection due to climate
5.1.1.2. High awareness levels pertaining to myriad fungal infections
5.1.1.3. Increased demand for the drugs to combat the related diseases
5.1.1.4. Favorable government initiative and corporate funds
5.1.2. Restraints
5.1.2.1. Continued preference for conventional antifungal drugs
5.1.2.2. Growing population with antifungal drug resistance
5.1.3. Opportunities
5.1.3.1. Increased R&D funding and focus on product innovation
5.1.3.2. Patent expiration of branded drugs
5.1.4. Challenges
5.1.4.1. Potential side effects
5.1.4.2. Presence of counterfeit drugs and resistance toward antifungal drugs
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ANTIFUNGAL DRUG MARKET, BY INFECTION TYPE
6.1. Introduction
6.2. Superficial Fungal Infection
6.3. Systemic Fungal infection
7. GLOBAL ANTIFUNGAL DRUG MARKET, BY TYPE
7.1. Introduction
7.2. Allylamines
7.2.1. Butenafine
7.2.2. Naftifine
7.2.3. Terbinafine
7.3. Azoles
7.3.1. Imidazoles
7.3.2. Thiazoles
7.3.3. Voricanazole
7.4. Echinocandins
7.4.1. Anidulafungin
7.4.2. Caspofungin
7.4.3. Micafungin
7.5. Polyenes
7.5.1. Amphotericin B
7.5.2. Candicidin
7.5.3. Hamycin
7.5.4. Natamycin
8. GLOBAL ANTIFUNGAL DRUG MARKET, BY FORM
8.1. Introduction
8.2. Ointments
8.3. Powder
8.4. Tablets
9. GLOBAL ANTIFUNGAL DRUG MARKET, BY THERAPEUTIC INDICATIONS
9.1. Introduction
9.2. Aspergillosis
9.3. Candidiasis
9.4. Dermatophytosis
10. AMERICAS ANTIFUNGAL DRUG MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Abbott Laboratories
14.2. Astellas Pharma Inc.
14.3. Bayer HealthCare Pharmaceuticals LLC
14.4. Cadila Pharmaceuticals Limited
14.5. Cipla, Inc.
14.6. Eli Lilly and Company
14.7. Enzon Pharmaceuticals, Inc.
14.8. G&W Laboratories LLC
14.9. Gilead Sciences, Inc.
14.10. Johnson & Johnson
14.11. Kramer Laboratories, Inc.
14.12. Lakewood-Amedex, Inc.
14.13. Merck KGaA
14.14. Novartis AG
14.15. Pfizer, Inc.
14.16. Ranbaxy Laboratories Limited
14.17. Sanofi S.A.
14.18. SCYNEXIS, Inc.
14.19. Sigma-Aldrich, Inc.
14.20. Wockhardt Limited
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Infection Type Outlook
3.4. Type Outlook
3.5. Form Outlook
3.6. Therapeutic Indications Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of fungal infection due to climate
5.1.1.2. High awareness levels pertaining to myriad fungal infections
5.1.1.3. Increased demand for the drugs to combat the related diseases
5.1.1.4. Favorable government initiative and corporate funds
5.1.2. Restraints
5.1.2.1. Continued preference for conventional antifungal drugs
5.1.2.2. Growing population with antifungal drug resistance
5.1.3. Opportunities
5.1.3.1. Increased R&D funding and focus on product innovation
5.1.3.2. Patent expiration of branded drugs
5.1.4. Challenges
5.1.4.1. Potential side effects
5.1.4.2. Presence of counterfeit drugs and resistance toward antifungal drugs
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ANTIFUNGAL DRUG MARKET, BY INFECTION TYPE
6.1. Introduction
6.2. Superficial Fungal Infection
6.3. Systemic Fungal infection
7. GLOBAL ANTIFUNGAL DRUG MARKET, BY TYPE
7.1. Introduction
7.2. Allylamines
7.2.1. Butenafine
7.2.2. Naftifine
7.2.3. Terbinafine
7.3. Azoles
7.3.1. Imidazoles
7.3.2. Thiazoles
7.3.3. Voricanazole
7.4. Echinocandins
7.4.1. Anidulafungin
7.4.2. Caspofungin
7.4.3. Micafungin
7.5. Polyenes
7.5.1. Amphotericin B
7.5.2. Candicidin
7.5.3. Hamycin
7.5.4. Natamycin
8. GLOBAL ANTIFUNGAL DRUG MARKET, BY FORM
8.1. Introduction
8.2. Ointments
8.3. Powder
8.4. Tablets
9. GLOBAL ANTIFUNGAL DRUG MARKET, BY THERAPEUTIC INDICATIONS
9.1. Introduction
9.2. Aspergillosis
9.3. Candidiasis
9.4. Dermatophytosis
10. AMERICAS ANTIFUNGAL DRUG MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Abbott Laboratories
14.2. Astellas Pharma Inc.
14.3. Bayer HealthCare Pharmaceuticals LLC
14.4. Cadila Pharmaceuticals Limited
14.5. Cipla, Inc.
14.6. Eli Lilly and Company
14.7. Enzon Pharmaceuticals, Inc.
14.8. G&W Laboratories LLC
14.9. Gilead Sciences, Inc.
14.10. Johnson & Johnson
14.11. Kramer Laboratories, Inc.
14.12. Lakewood-Amedex, Inc.
14.13. Merck KGaA
14.14. Novartis AG
14.15. Pfizer, Inc.
14.16. Ranbaxy Laboratories Limited
14.17. Sanofi S.A.
14.18. SCYNEXIS, Inc.
14.19. Sigma-Aldrich, Inc.
14.20. Wockhardt Limited
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ALLYLAMINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY BUTENAFINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY NAFTIFINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TERBINAFINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AZOLES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY IMIDAZOLES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THIAZOLES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY VORICANAZOLE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ECHINOCANDINS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ANIDULAFUNGIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CASPOFUNGIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY MICAFUNGIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POLYENES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AMPHOTERICIN B, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDICIDIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY HAMYCIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY NATAMYCIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY OINTMENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POWDER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TABLETS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ASPERGILLOSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDIDIASIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY DERMATOPHYTOSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ARGENTINA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ARGENTINA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ARGENTINA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ARGENTINA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. BRAZIL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. BRAZIL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. BRAZIL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. BRAZIL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. CANADA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CANADA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. CANADA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. CANADA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. MEXICO ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. MEXICO ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. MEXICO ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. MEXICO ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. AUSTRALIA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. AUSTRALIA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. AUSTRALIA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. AUSTRALIA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. CHINA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. CHINA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. CHINA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. CHINA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. INDIA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. INDIA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. INDIA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. INDIA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. INDONESIA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. INDONESIA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. INDONESIA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. INDONESIA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. JAPAN ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. JAPAN ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. JAPAN ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. JAPAN ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. MALAYSIA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. MALAYSIA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. MALAYSIA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. MALAYSIA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. PHILIPPINES ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. PHILIPPINES ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. PHILIPPINES ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. PHILIPPINES ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SOUTH KOREA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH KOREA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SOUTH KOREA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SOUTH KOREA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. THAILAND ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. THAILAND ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. THAILAND ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. THAILAND ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. FRANCE ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. FRANCE ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. FRANCE ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. FRANCE ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. GERMANY ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. GERMANY ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. GERMANY ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. GERMANY ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. ITALY ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. ITALY ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. ITALY ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. ITALY ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. NETHERLANDS ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. NETHERLANDS ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. NETHERLANDS ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. NETHERLANDS ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. QATAR ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. QATAR ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. QATAR ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. QATAR ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. RUSSIA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. RUSSIA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. RUSSIA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. RUSSIA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. SAUDI ARABIA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. SAUDI ARABIA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. SAUDI ARABIA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. SAUDI ARABIA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. SOUTH AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. SOUTH AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. SOUTH AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. SOUTH AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. SPAIN ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. SPAIN ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. SPAIN ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. SPAIN ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. UNITED ARAB EMIRATES ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. UNITED ARAB EMIRATES ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 142. UNITED ARAB EMIRATES ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 143. UNITED ARAB EMIRATES ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 144. UNITED KINGDOM ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 145. UNITED KINGDOM ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 146. UNITED KINGDOM ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 147. UNITED KINGDOM ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 148. GLOBAL ANTIFUNGAL DRUG MARKET: SCORES
TABLE 149. GLOBAL ANTIFUNGAL DRUG MARKET: BUSINESS STRATEGY
TABLE 150. GLOBAL ANTIFUNGAL DRUG MARKET: PRODUCT SATISFACTION
TABLE 151. GLOBAL ANTIFUNGAL DRUG MARKET: RANKING
TABLE 152. GLOBAL ANTIFUNGAL DRUG MARKET: MERGER & ACQUISITION
TABLE 153. GLOBAL ANTIFUNGAL DRUG MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 154. GLOBAL ANTIFUNGAL DRUG MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 155. GLOBAL ANTIFUNGAL DRUG MARKET: INVESTMENT & FUNDING
TABLE 156. GLOBAL ANTIFUNGAL DRUG MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 157. GLOBAL ANTIFUNGAL DRUG MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ALLYLAMINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY BUTENAFINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY NAFTIFINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TERBINAFINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AZOLES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY IMIDAZOLES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THIAZOLES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY VORICANAZOLE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ECHINOCANDINS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ANIDULAFUNGIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CASPOFUNGIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY MICAFUNGIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POLYENES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AMPHOTERICIN B, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDICIDIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY HAMYCIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY NATAMYCIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY OINTMENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POWDER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TABLETS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ASPERGILLOSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDIDIASIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY DERMATOPHYTOSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ARGENTINA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ARGENTINA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ARGENTINA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ARGENTINA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. BRAZIL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. BRAZIL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. BRAZIL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. BRAZIL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. CANADA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CANADA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. CANADA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. CANADA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. MEXICO ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. MEXICO ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. MEXICO ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. MEXICO ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. AUSTRALIA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. AUSTRALIA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. AUSTRALIA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. AUSTRALIA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. CHINA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. CHINA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. CHINA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. CHINA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. INDIA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. INDIA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. INDIA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. INDIA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. INDONESIA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. INDONESIA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. INDONESIA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. INDONESIA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. JAPAN ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. JAPAN ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. JAPAN ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. JAPAN ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. MALAYSIA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. MALAYSIA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. MALAYSIA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. MALAYSIA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. PHILIPPINES ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. PHILIPPINES ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. PHILIPPINES ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. PHILIPPINES ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SOUTH KOREA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH KOREA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SOUTH KOREA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SOUTH KOREA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. THAILAND ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. THAILAND ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. THAILAND ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. THAILAND ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. FRANCE ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. FRANCE ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. FRANCE ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. FRANCE ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. GERMANY ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. GERMANY ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. GERMANY ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. GERMANY ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. ITALY ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. ITALY ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. ITALY ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. ITALY ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. NETHERLANDS ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. NETHERLANDS ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. NETHERLANDS ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. NETHERLANDS ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. QATAR ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. QATAR ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. QATAR ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. QATAR ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. RUSSIA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. RUSSIA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. RUSSIA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. RUSSIA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. SAUDI ARABIA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. SAUDI ARABIA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. SAUDI ARABIA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. SAUDI ARABIA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. SOUTH AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. SOUTH AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. SOUTH AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. SOUTH AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. SPAIN ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. SPAIN ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. SPAIN ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. SPAIN ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. UNITED ARAB EMIRATES ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. UNITED ARAB EMIRATES ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 142. UNITED ARAB EMIRATES ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 143. UNITED ARAB EMIRATES ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 144. UNITED KINGDOM ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 145. UNITED KINGDOM ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 146. UNITED KINGDOM ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 147. UNITED KINGDOM ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 148. GLOBAL ANTIFUNGAL DRUG MARKET: SCORES
TABLE 149. GLOBAL ANTIFUNGAL DRUG MARKET: BUSINESS STRATEGY
TABLE 150. GLOBAL ANTIFUNGAL DRUG MARKET: PRODUCT SATISFACTION
TABLE 151. GLOBAL ANTIFUNGAL DRUG MARKET: RANKING
TABLE 152. GLOBAL ANTIFUNGAL DRUG MARKET: MERGER & ACQUISITION
TABLE 153. GLOBAL ANTIFUNGAL DRUG MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 154. GLOBAL ANTIFUNGAL DRUG MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 155. GLOBAL ANTIFUNGAL DRUG MARKET: INVESTMENT & FUNDING
TABLE 156. GLOBAL ANTIFUNGAL DRUG MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 157. GLOBAL ANTIFUNGAL DRUG MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL ANTIFUNGAL DRUG MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIFUNGAL DRUG MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2020 (USD MILLION)
FIGURE 7. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2020 (USD MILLION)
FIGURE 8. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL ANTIFUNGAL DRUG MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL ANTIFUNGAL DRUG MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2020 VS 2025 (%)
FIGURE 16. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2025
FIGURE 18. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 21. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2025
FIGURE 23. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ALLYLAMINES, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY BUTENAFINE, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY NAFTIFINE, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TERBINAFINE, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AZOLES, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY IMIDAZOLES, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THIAZOLES, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY VORICANAZOLE, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ECHINOCANDINS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ANIDULAFUNGIN, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CASPOFUNGIN, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY MICAFUNGIN, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POLYENES, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AMPHOTERICIN B, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDICIDIN, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY HAMYCIN, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY NATAMYCIN, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2020 VS 2025 (%)
FIGURE 41. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2025
FIGURE 43. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY OINTMENTS, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POWDER, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TABLETS, 2020 VS 2025 (USD MILLION)
FIGURE 46. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2020 VS 2025 (%)
FIGURE 47. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2025
FIGURE 49. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ASPERGILLOSIS, 2020 VS 2025 (USD MILLION)
FIGURE 50. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDIDIASIS, 2020 VS 2025 (USD MILLION)
FIGURE 51. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY DERMATOPHYTOSIS, 2020 VS 2025 (USD MILLION)
FIGURE 52. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 53. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 55. ARGENTINA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. BRAZIL ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. CANADA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. MEXICO ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 61. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 63. AUSTRALIA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. CHINA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. INDIA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. INDONESIA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. JAPAN ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. MALAYSIA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. PHILIPPINES ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SOUTH KOREA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. THAILAND ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 74. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 75. FRANCE ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. GERMANY ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 77. ITALY ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 78. NETHERLANDS ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 79. QATAR ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 80. RUSSIA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 81. SAUDI ARABIA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 82. SOUTH AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 83. SPAIN ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 84. UNITED ARAB EMIRATES ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 85. UNITED KINGDOM ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 86. GLOBAL ANTIFUNGAL DRUG MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 87. GLOBAL ANTIFUNGAL DRUG MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 88. GLOBAL ANTIFUNGAL DRUG MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 89. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTIFUNGAL DRUG MARKET, BY TYPE
FIGURE 1. GLOBAL ANTIFUNGAL DRUG MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIFUNGAL DRUG MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2020 (USD MILLION)
FIGURE 7. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2020 (USD MILLION)
FIGURE 8. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL ANTIFUNGAL DRUG MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL ANTIFUNGAL DRUG MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2020 VS 2025 (%)
FIGURE 16. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2025
FIGURE 18. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 21. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2025
FIGURE 23. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ALLYLAMINES, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY BUTENAFINE, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY NAFTIFINE, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TERBINAFINE, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AZOLES, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY IMIDAZOLES, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THIAZOLES, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY VORICANAZOLE, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ECHINOCANDINS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ANIDULAFUNGIN, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CASPOFUNGIN, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY MICAFUNGIN, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POLYENES, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AMPHOTERICIN B, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDICIDIN, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY HAMYCIN, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY NATAMYCIN, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2020 VS 2025 (%)
FIGURE 41. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2025
FIGURE 43. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY OINTMENTS, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POWDER, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TABLETS, 2020 VS 2025 (USD MILLION)
FIGURE 46. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2020 VS 2025 (%)
FIGURE 47. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2025
FIGURE 49. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ASPERGILLOSIS, 2020 VS 2025 (USD MILLION)
FIGURE 50. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDIDIASIS, 2020 VS 2025 (USD MILLION)
FIGURE 51. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY DERMATOPHYTOSIS, 2020 VS 2025 (USD MILLION)
FIGURE 52. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 53. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 55. ARGENTINA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. BRAZIL ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. CANADA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. MEXICO ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 61. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 63. AUSTRALIA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. CHINA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. INDIA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. INDONESIA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. JAPAN ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. MALAYSIA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. PHILIPPINES ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SOUTH KOREA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. THAILAND ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 74. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 75. FRANCE ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. GERMANY ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 77. ITALY ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 78. NETHERLANDS ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 79. QATAR ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 80. RUSSIA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 81. SAUDI ARABIA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 82. SOUTH AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 83. SPAIN ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 84. UNITED ARAB EMIRATES ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 85. UNITED KINGDOM ANTIFUNGAL DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 86. GLOBAL ANTIFUNGAL DRUG MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 87. GLOBAL ANTIFUNGAL DRUG MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 88. GLOBAL ANTIFUNGAL DRUG MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 89. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTIFUNGAL DRUG MARKET, BY TYPE
